Introduction 52
Type III polyketide synthases (PKSs) are simple homodimers of ketosynthases that 53 condense an extender substrate(s) onto a starter substrate iteratively by decarboxylative 54
Claisen condensation reactions (1) . They also catalyze the cyclization of the resulting 55 β-ketoacyl-molecule to give aromatic polyketides (1) . Type III PKSs are distributed in 56 diverse organisms, including plants, fungi and bacteria, and are responsible for the 57 syntheses of various biologically and pharmaceutically important compounds (1) . In 58 1999, we revealed the function of the first bacterial type III PKS, 59
1,3,6,8-tetrahydroxynaphthalene synthase RppA, from the Gram-positive, filamentous 60 bacterium Streptomyces griseus (5). The complete genome sequence of S. griseus 61 subsequently revealed another type III PKS gene (srsA) (12). We previously 62 characterized the function of the srs operon, which consists of srsA, srsB and srsC (7). 63
It is responsible for the production of methylated phenolic lipids, which confer 64 resistance to β-lactam antibiotics on the producer strain (7). We proposed a biosynthetic 65 pathway for the methylated phenolic lipids, as shown in Figure 1A (7). First, the type III 66 PKS SrsA synthesizes 3-alkyl-4-methylresorcinols. The O-methyltransferase SrsB then 67 catalyzes the O-methylation of the 3-alkyl-4-methylresorcinols to yield 68 3-alkyl-4-methylresorcinol-1-methyl ethers. Finally, the hydroxylase SrsC hydroxylates 69 the alkyl-methylresorcinol-methyl ethers, resulting in 70 6-alkyl-2-methoxy-5-methylhydroquinones, which undergo spontaneous oxidation to 71
give 6-alkyl-2-methoxy-5-methylquinones. However, detailed in vitro analyses are 72 required to confirm the proposed enzymatic reactions, especially those reactions 73 catalyzed by SrsA and SrsB, for the reasons given below. 74
The type III PKS gene, srsA, was found to direct the production of alkylresorcinols 75 using intrinsic branched-chain fatty acids as starter units (for example iso-C 15 , iso-C 16 , 76 iso-C 17 and anteiso-C 17 fatty acids) when expressed in Streptomyces lividans (7). The 77 recombinant SrsA protein also produced 3-(13'-methyltetradecyl)-4-methylresorcinol 78 on September 23, 2017 by guest http://jb.asm.org/ Downloaded from 7 membrane fractions, respectively. 160
161
Production and purification of C-terminally His 6 -tagged SrsB: S. lividans TK21 162 harboring pHSA81-srsBhis was used to inoculate YEME medium (200 ml) containing 5 163 μg/ml thiostrepton and incubated at 30°C for 72 h. Cells were harvested by 164 centrifugation and resuspended in buffer B (50 mM Tris-HCl, 150 mM NaCl, 5 mM 165 imidazole, 10% glycerol, pH 8.0, 20 ml), then disrupted by sonication. The crude 166 extract was prepared by removal of the cell debris by centrifugation at 10,000 x g for 20 167
min. The crude extract was centrifuged at 150,000 x g for 1 h at 4°C, to pellet the 168 membrane. SrsB-containing membranes were suspended in buffer B containing 0.1% 169 n-dodecyl-β-D-maltopyranoside (DDM) (20 ml) at 4°C for 30 min. The solution was 170 subsequently centrifuged at 300,000 x g for 1 h at 4°C, to remove the membrane. The 171 supernatant containing solubilized SrsB was applied to a nickel-nitrilotriacetic acid 172 Trp-350)-DPNSSSVDKLAAALE-His 6 , was prepared as described previously (7). The 184 reaction mixture consisted of 50 mM Tris-HCl (pH 8.0), 100 μM iC 16 -CoA, 100 μM 185 extender substrates (Fig. 1A) (7) . To analyzed the order of extender substrate 247 condensation, we examined an in vitro SrsA reaction using [ 13 C 3 ]malonyl-CoA, in 248 which all three carbon atoms of the malonate-moiety are labeled with 13 C. The structure 249 of 1 allows two possible extender substrate condensation patterns to be proposed. The 250 first pattern involves the condensation of one methylmalonyl-CoA extender unit, 251 followed by two malonyl-CoAs (Fig. 2, upper) . In this case, three [
13 C] carbon atoms 252 would be expected to be incorporated into compound 1 when SrsA is incubated with 253 (Fig. 2, lower) . In contrast to the first pattern, four [
13 C] carbon 256 atoms would be expected to be incorporated into compound 1 in this case. LC-APCIMS 257 analysis of compound 1 produced by the reaction mixture containing 258 (Fig. 3) , in accordance with our previous result (7). However, trace quantities 268 of another product (compound 3) were also detected in the reaction. When the 269 incubation period was shortened to 5 min, compound 3 was detected as the major 270 product, and only trace quantities of compound 1 were observed (Fig. 3) .
mixtures were analyzed by radio-TLC (Fig. 4A) . Compound 3 was the major product 275 observed after 5 min incubation time, but the amount present decreased as the 276 incubation period was prolonged, with none detected after incubation times of 45 and 277 60 min. In contrast, compound 1 was the minor product after 5 min of incubation, but 278 was detected in increasingly high proportions after prolonged incubation. This result 279 indicated that 3 was the initial product of the reaction, and was then converted to 1. In 280
LC-APCIMS analysis, a [M-H]
-molecular ion peak at m/z 377.3 was observed for 281 compound 3 (data not shown), indicating that the molecular weight (MW) of 3 is 378.3 282 Da, 44 Da larger than that of 1 (corresponding to the molecular weight of a molecule of 283 CO 2 ). From these results, together with the condensation order of the extender 284 substrates described above (Fig. 2, upper) , we concluded that compound 3 was 285 2-(13'-methyltetradecyl)-3-methylresorcylic acid (MW 378.3, see Fig. 1B for structure) . 286
We also concluded that this alkylresorcylic acid was the direct product of SrsA, rather 287 than the alkylresorcinol 1 originally proposed. into S. lividans, and production of SrsB was analyzed by SDS-PAGE (Fig. 5A) . The 295 recombinant SrsB protein (MW approximately 19 kDa) was detected in the crude 296 cell-free extract of S. lividans harboring pIJ6021-srsB, and was absent in a control strain 297 (S. lividans harboring the empty vector pIJ6021, Figure 5A , soluble fraction (lane S)). 298
Note that the soluble fraction contained both cytoplasmic and membrane proteins. We 299 used the cell-free crude extract of S. lividans harboring pIJ6021-srsB for studies of the 300 in vitro SrsB catalyzed reaction. 301
Since the direct product of SrsA had been revealed to be alkylresorcylic acid, as 302 described above, we postulated that the genuine substrate of SrsB is not alkylresorcinol 303 but alkylresorcylic acid. However, alkylresorcylic acid cannot be readily prepared for 304 use as a substrate in in vitro experiments, due to its facile decarboxylation. We therefore 305 (Fig. 4C) . As expected, a new product (compound 2) was detected, even 311 after only 5 min of incubation (Fig. 4C) . When SAM was absent from the reaction 312 mixture, compound 2 was not observed (Fig. 4B ), indicating that 2 is the product of the 313 methylation of alkylresorcylic acid 3 or alkylresorcinol 1. We next examined the 314 reaction using non-labeled substrates. When the reaction mixture generated after 5 min 315 of incubation was analyzed by LC-APCIMS, the production of 2 was again observed 316 (Fig. 6B) . Compound 2 was not detected when either the SrsB-containing crude extract, 317 or SAM, were absent from the reaction mixture (Fig. 6A) . Alkylresorcinol 1 and its 318 O-methylated form (the hydroxyl group at C-1 of 1 is O-methylated), which had been 319 previously purified from S. lividans strains expressing srsA and srsAB, respectively (7), 320 were used as authentic samples to determine the structure of 2 (Fig. 6C ). This allowed 321 on September 23, 2017 by guest http://jb.asm.org/ Downloaded from 13 compound 2 to be identified as the alkylresorcinol methyl ether. Note that, in the in vitro 322
SrsAB reaction (Fig. 4C and 6B) , we did not detect any other products that could give 323 evidence for the formation of O-methylated alkylresorcylic acid. 324
Next, we examined whether SrsB could use alkylresorcinol 1 as a substrate. The 325 SrsB-containing crude extract was incubated at 30°C for 2 h with alkylresorcinol 1 in 326 the presence of SAM, and the reaction mixture was analyzed by HPLC. No conversion 327 of alkylresorcinol 1 was detected (Fig. S2) . This result strongly indicated that the 328 genuine substrate of SrsB in the in vitro SrsAB reaction was alkylresorcylic acid 3, 329 rather than alkylresorcinol 1. Conversion of alkylresorcylic acid 3 to alkylresorcinol 330 methyl ether 2 requires not only O-methylation of the hydroxyl group at C-6 of 3, but 331 also decarboxylation of 3 (Fig. 1B) . Because the alkylresorcylic acid 3 is readily 332 converted to alkylresorcinols by facile non-enzymatic decarboxylation (Fig. 3 and 4) , 333
we could not purify the alkylresorcylic acid 3 for a further in vitro analysis of SrsB. The 334 reaction catalyzed by SrsB is discussed further in the Discussion section. 335
336
Localization of SrsB in the membrane. Prediction of the localization of SrsB using 337 the SOSUI program indicated that SrsB is likely to be a membrane-bound protein.
To 338 confirm this, we separated the SrsB-containing crude extract into cytoplasmic and 339 membrane fractions by high-speed centrifugation (150,000 x g for 1 h at 4°C). The 340 recombinant SrsB protein was detected in the membrane fraction by SDS-PAGE (Fig.  341   5A) . SrsB activity was also detected in the membrane fraction but not in the 342 cytoplasmic fraction, as determined by radio-TLC analysis (Fig. 5C ). From these results, 343
we concluded that SrsB is localized in the cell membrane. Alkylresorcylic acid, the 344 substrate of SrsB, is likely to be localized in the cell membrane, so the localization of 345 SrsB in the membrane is reasonable. 346
347
In vitro analysis using purified SrsB. As described above, SrsB activity was detected 348 on September 23, 2017 by guest http://jb.asm.org/ Downloaded from 14 in the membrane fraction of S. lividans expressing srsB. We next attempted to purify the 349 recombinant SrsB protein from the membrane fraction, and C-terminally His 6 -tagged 350
SrsB protein was produced in S. lividans. The His 6 -tagged SrsB protein was detected in 351 the membrane fraction by SDS-PAGE, as expected (Fig. 5B, lane 1) . The 352 SrsB-containing membrane was suspended in a buffer containing 0.1% DDM and 353 incubated at 4°C for 30 min to solubilize the His 6 -tagged SrsB protein from the 354 membrane. The solution was subsequently centrifuged at 300,000 x g for 1 h at 4°C, to 355 remove the membrane (Fig. 5B, lanes 2 and 3) . The solubilized His 6 -tagged SrsB was 356 purified from the supernatant by Ni-NTA superflow chromatography to give a single 357 major protein band of 20 kDa on SDS-PAGE (Fig. 5B, lane 4) . The purified His 6 -tagged 358
SrsB showed clear SrsB activity, as determined by radio-TLC analysis (Fig. 5C ). This 359 result indicates that no additional enzymes are required for the conversion of 360 alkylresorcylic acid 3 to alkylresorcinol methyl ether 2 by SrsB. SrsA produces alkylresorcylic acid 3, which is tautomerized to 3'. Then, the methyl 568 group of SAM is transferred onto the oxygen atom at C-6 of 3' by SrsB, accompanied 569 by the decarboxylation of 3', to produce the alkylresorcinol methyl ether 2. B) 570
Mechanism of non-enzymatic decarboxylation of alkylresorcylic acid to produce 571 alkylresorcinol. Decarboxylation occurs via tautomerism of alkylresorcylic acid. 
